S. Dennis

19.3k total citations · 1 hit paper
339 papers, 13.2k citations indexed

About

S. Dennis is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, S. Dennis has authored 339 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Reproductive Medicine, 192 papers in Surgery and 161 papers in Obstetrics and Gynecology. Recurrent topics in S. Dennis's work include Ovarian cancer diagnosis and treatment (222 papers), Endometrial and Cervical Cancer Treatments (143 papers) and Intraperitoneal and Appendiceal Malignancies (132 papers). S. Dennis is often cited by papers focused on Ovarian cancer diagnosis and treatment (222 papers), Endometrial and Cervical Cancer Treatments (143 papers) and Intraperitoneal and Appendiceal Malignancies (132 papers). S. Dennis collaborates with scholars based in United States, Germany and United Kingdom. S. Dennis's co-authors include Richard R. Barakat, Nadeem R. Abu‐Rustum, Robert E. Bristow, Yukio Sonoda, Mario M. Leitão, Oliver Zivanovic, Yukio Sonoda, Douglas A. Levine, Carol Aghajanian and Eric Eisenhauer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

S. Dennis

330 papers receiving 12.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

2009 441 citations S. Dennis, Eric Eisenhauer et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Dennis United States	60	9.0k	7.2k	6.3k	2.4k	1.7k	339	13.2k
Robert E. Bristow United States	65	10.4k 1.2×	6.3k 0.9×	6.5k 1.0×	2.9k 1.2×	1.6k 0.9×	313	15.2k
Nadeem R. Abu‐Rustum United States	67	10.8k 1.2×	11.6k 1.6×	5.4k 0.9×	2.7k 1.2×	2.1k 1.2×	473	17.5k
Mario M. Leitão United States	57	5.6k 0.6×	7.1k 1.0×	2.7k 0.4×	2.4k 1.0×	1.7k 1.0×	331	11.1k
Richard R. Barakat United States	70	10.0k 1.1×	9.6k 1.3×	5.3k 0.8×	3.5k 1.5×	2.4k 1.4×	286	18.0k
Anna Fagotti Italy	51	5.6k 0.6×	4.7k 0.7×	4.7k 0.8×	1.5k 0.6×	723 0.4×	393	9.0k
Michael Frumovitz United States	52	3.8k 0.4×	5.8k 0.8×	2.4k 0.4×	2.3k 1.0×	878 0.5×	262	9.2k
William T. Creasman United States	66	8.3k 0.9×	10.9k 1.5×	3.8k 0.6×	2.9k 1.2×	2.0k 1.2×	243	17.4k
Patricia J. Eifel United States	59	3.7k 0.4×	8.3k 1.2×	4.7k 0.8×	2.7k 1.2×	1.9k 1.1×	263	13.3k
Nick M. Spirtos United States	41	5.8k 0.6×	6.2k 0.9×	2.8k 0.4×	1.2k 0.5×	847 0.5×	94	8.6k
Charles Levenback United States	42	2.6k 0.3×	4.5k 0.6×	2.6k 0.4×	1.5k 0.6×	962 0.6×	102	6.9k

Countries citing papers authored by S. Dennis

Since Specialization

Citations

This map shows the geographic impact of S. Dennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Dennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Dennis more than expected).

Fields of papers citing papers by S. Dennis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Dennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Dennis. The network helps show where S. Dennis may publish in the future.

Co-authorship network of co-authors of S. Dennis

This figure shows the co-authorship network connecting the top 25 collaborators of S. Dennis. A scholar is included among the top collaborators of S. Dennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Dennis. S. Dennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kahn, Ryan, Kieran J. Murphy, Qin Zhou, et al.. (2025). Three-dimensional volumetric rendering on augmented reality headsets for ovarian cancer cytoreduction planning: A Memorial Sloan Kettering Cancer Center Team Ovary study. Gynecologic Oncology. 196. 107–112. 1 indexed citations

Ellozy, Sharif H., et al.. (2024). Vascular resection and reconstruction in recurrent granulosa cell tumor. Gynecologic Oncology Reports. 55. 101496–101496. 1 indexed citations

Filippova, Olga T., Vance Broach, Ginger J. Gardner, et al.. (2024). Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study. Gynecologic Oncology. 187. 80–84. 2 indexed citations

Sullivan, Mackenzie W., Qin Zhou, Lora H. Ellenson, et al.. (2024). Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer. Cancer. 131(1). e35523–e35523. 3 indexed citations

Yaari, Zvi, Ron Feiner, Arnaud Da Cruz Paula, et al.. (2024). Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations. Gynecologic Oncology Reports. 51. 101330–101330. 2 indexed citations

Dennis, S., et al.. (2023). An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer. Journal of Gynecologic Oncology. 34(5). e84–e84. 2 indexed citations

Manning‐Geist, Beryl, Renee A. Cowan, Brooke A. Schlappe, et al.. (2022). Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study. Gynecologic Oncology Reports. 40. 100940–100940. 4 indexed citations

Gu, Shengqing, Stéphanie Lheureux, Azin Sayad, et al.. (2021). Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening. Proceedings of the National Academy of Sciences. 118(25). 12 indexed citations

Aviki, Emeline, Beryl Manning‐Geist, Tiffanny Newman, et al.. (2021). Risk factors for financial toxicity in patients with gynecologic cancer. American Journal of Obstetrics and Gynecology. 226(6). 817.e1–817.e9. 37 indexed citations

10.

Boerner, Thomas, Oliver Zivanovic, & S. Dennis. (2021). Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer. Journal of Gastrointestinal Oncology. 12(S1). S137–S143. 4 indexed citations

11.

Liu, Ying L., Olga T. Filippova, Qin Zhou, et al.. (2019). Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of Gynecologic Oncology. 31(1). e17–e17. 23 indexed citations

12.

Tseng, Jill, R.S. Suidan, Oliver Zivanovic, et al.. (2016). Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic Oncology. 142(2). 217–224. 41 indexed citations

13.

Sandadi, Samith, K. Long, Vaagn Andikyan, et al.. (2013). Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer. Gynecologic Oncology. 132(2). 299–302. 13 indexed citations

14.

Kolev, Valentin, Svetlana Mironov, Oleg Mironov, et al.. (2010). Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 20(6). 979–984. 39 indexed citations

15.

Seshan, Venkatraman, Douglas A. Levine, Yukio Sonoda, et al.. (2009). A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. Gynecologic Oncology. 114(1). 111–116. 48 indexed citations

16.

Diaz, John P., William P. Tew, Oliver Zivanovic, et al.. (2009). Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma. Gynecologic Oncology. 116(3). 335–339. 34 indexed citations

17.

Dennis, S., Oliver Zivanovic, Eric Eisenhauer, et al.. (2008). A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecologic Oncology. 112(1). 6–10. 73 indexed citations

18.

Hensley, Martee L., Denise D. Correa, Howard T. Thaler, et al.. (2006). Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology. 102(2). 270–277. 25 indexed citations

19.

Dennis, S., John B. Liao, Larry Léon, et al.. (2001). Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma. Gynecologic Oncology. 82(3). 532–537. 201 indexed citations

20.

Dennis, S. & Paul Sabbatini. (2000). Advanced ovarian cancer. Current Treatment Options in Oncology. 1(2). 139–146. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact